Hoodin (HOODIN) Q2 2025 earnings summary

Executive summary

• Achieved significant platform expansion, adding over 5,000 new regulatory frameworks, including comprehensive coverage for the US and Canada.

• Launched Smart Compliance List, the first AI-supported solution for harmonized regulatory management in life science.

• Secured two new global life science customers and conducted online training for over 100 industry professionals.

• Positioned for growth as regulatory deadlines in Medtech and IVD sectors intensify demand for digital compliance solutions.

Financial highlights

• Q2 2025 net revenue was 384 KSEK, up from 237 KSEK year-over-year.

• Operating loss for Q2 was -1,400 KSEK, compared to -1,321 KSEK last year.

• Net loss after tax for Q2 was -1,537 KSEK, versus -1,320 KSEK year-over-year.

• H1 2025 net revenue reached 598 KSEK, up from 479 KSEK year-over-year.

• Cash and cash equivalents at period end were 5,299 KSEK, up from 4,501 KSEK last year.

Outlook and guidance

• Anticipates strong growth opportunities as regulatory changes drive demand for compliance solutions in life science.

• Expects continued positive sales development, though long sales cycles delay revenue recognition.

• Plans to expand platform coverage with EU regulatory guidances in autumn 2025.